Markets

The Fundamental Case for and Against Exelixis, Inc. (EXEL)

Exelixis, Inc. (NASDAQ:EXEL) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading with a market value of 6.35B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Exelixis, Inc. (NASDAQ:EXEL) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For EXEL, the company currently has 232.84 million of cash on the books. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 774.92 million in total assets, balanced by 105.15 million in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Exelixis, Inc. (EXEL) saw 68.86 million in free cash flow last quarter, representing a quarterly net change in cash of 46.02 million. Perhaps most importantly where cash movements are concerned, the company saw about 71.81 million in net operating cash flow.

Exelixis, Inc. (NASDAQ:EXEL) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 212.35 million in total revenues. That represents a quarterly year/year change in revenues of 1.63 in sequential terms, the EXEL saw sales decline by 0.77.



But what about the bottom line? After all, that’s what really matters in the end. Exelixis, Inc. (EXEL) is intriguing when broken down to its core data. The cost of selling goods last quarter was 5.64 million, yielding a gross basic income of 206.71 million. For shareholders, given the total diluted outstanding shares of 313.69 million, this means overall earnings per share of 0.37. Note, this compares with a consensus analyst forecast of 0.14 in earnings per share for its next fiscal quarterly report.

Is Exelixis, Inc. (NASDAQ:EXEL) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 1.10 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 20.48. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Exelixis, Inc..

Previous ArticleNext Article

Related Post

The Fundamental Facts on VEON Ltd. (VEON) VEON Ltd. (NASDAQ:VEON) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now trading w...
How Does the Fundamental Picture Look for Hallibur... It is interesting to note that Halliburton Company (NYSE:HAL) is active and made a solid movement in the last trading day. Now trading with a market v...
How Does the Fundamental Picture Look for GNC Hold... GNC Holdings, Inc. (NYSE:GNC) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a market value of...
It’s worth it to have a look at Verastem, In... It is interesting to note that Verastem, Inc. (NASDAQ:VSTM) is active and made a solid movement in the last trading day. Now trading with a market val...
Drilling Down Into the Books for ReShape Lifescien... ReShape Lifesciences Inc. (NASDAQ:RSLS) is one of the active stocks and its unusual movement is raising eyebrows among traders. Now trading with a mar...